Sun protection product now with a new FDA-approved filter
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, marking a modernization in U.S. UV protection. The ingredient absorbs both UVA and UVB rays, is photostable, and will debut as Parsol Shield before broader market adoption after an 18‑month exclusivity period. Industry and dermatology experts say the move could improve protection and user experience, though rollout and formulation timelines remain.
The FDA has approved bemotrizinol, a chemical UV filter used in European and Asian sunscreens for over 20 years. It offers UVA and UVB protection, is photostable, and may lead to more elegant, higher-SPF products in the US. The move comes after decades of FDA inaction on new filters, with products containing bemotrizinol expected to reach US shelves after about 18 months.